摘要
目的:研究冠心病(CHD)患者长期应用心脏保护性药物的治疗状况。方法:采用回顾性研究方法,对398例CHD患者进行随访观察。结果:CHD患者院内服用A、B、C和E比例分别为91．2%、87．2%、76．1%和76．1%,在平均(17．0±4．5)个月后,相应服药比例分别是93．9%、77．1%、51．9%和51．0%;服药剂量也呈减少趋势;停药原因中,医生未予处方的占30．3%,患者不合作24．7%,经济原因16．9%,换药及担心副反应10．0%,达标停药10．1%,5．6%由于服药过程中的不良反应而停药。结论:CHD患者长期服用有效药物的比例和剂量降低;患者认知和医生忽视是造成停药的主要因素。
Objective： To investigate the long - term therapy for patients with coronary heart disease in Beijing. Methods： This was a retrospective study, which enrolled 398 cases with CHD. Results： （1） The frequency of patients who took aspirin, βblocker, lipid - lowering drugs and ACEI was 91.2%, 87.2%, 76.1% and 76.1%, respectively, after 17 months follow- up, according, the value were 93.9%, 77.1%, 51.9% and 51.0% ; there was silmar tendency for all drug doses. （2） The cause resulting in discontinuing therapy follow： 30.3 % for doctor negloction, 24.7% for patient disobeying proscription, 16.9% for poor income, 10.0% for changing drug and anxious to side effect, 10.1% for attaining LDL- C the goal, 5.6% for occurring side effect.Conclusion： There were great gap for long - term treatment rates and effective doses, it resulted from patient recognition and doctor＇ negloction.
出处
《中国医药导刊》
2007年第3期194-196,共3页
Chinese Journal of Medicinal Guide
关键词
冠心病
服药率
中断治疗
coronary heart disease
treatment rates
discontinue therapy
